Ki Chung to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Ki Chung has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.475
-
Phase I study of two schedules of oral S-1 in combination with fixed doses of oxaliplatin and bevacizumab in patients with advanced solid tumors. Oncology. 2011; 81(2):65-72.
Score: 0.294
-
A Phase II Study of Durvalumab in Combination with Tremelimumab in Patients with Rare Cancers. Oncologist. 2021 09; 26(9):e1499-e1507.
Score: 0.143
-
A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer. Lung Cancer. 2022 01; 163:19-26.
Score: 0.037